<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2023.1133819</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Associations of macular microvascular parameters with cerebral small vessel disease in rural older adults: A population-based OCT angiography study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Xu</surname> <given-names>Zhe</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2152842/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Dong</surname> <given-names>Yi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1105107/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Yongxiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Song</surname> <given-names>Lin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2224713/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Niu</surname> <given-names>Sijie</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1156979/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Shanshan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname> <given-names>Mingqing</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2224249/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Jiafeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cong</surname> <given-names>Lin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1975112/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Han</surname> <given-names>Xiaojuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1180557/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hou</surname> <given-names>Tingting</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tang</surname> <given-names>Shi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Qinghua</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1683323/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Du</surname> <given-names>Yifeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/651920/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Qiu</surname> <given-names>Chengxuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/640385/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neurology, Shandong Provincial Hospital, Shandong University, Jinan</institution>, <addr-line>Shandong</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan</institution>, <addr-line>Shandong</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Shandong Provincial Clinical Research Center for Neurological Diseases, Jinan</institution>, <addr-line>Shandong</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Shandong Provincial Key Laboratory of Network Based Intelligent Computing, School of Information Science and Engineering, University of Jinan, Jinan</institution>, <addr-line>Shandong</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Aging Research Center and Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Stockholm University</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Alon Harris, Icahn School of Medicine at Mount Sinai, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Anna Fabczak-Kubicka, Icahn School of Medicine at Mount Sinai, United States; Aharon Wegner, Technical University of Munich, Germany</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Qinghua Zhang <email>cindy-217&#x00040;163.com</email></corresp>
<corresp id="c002">Yifeng Du <email>duyifeng2013&#x00040;163.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Neuro-Ophthalmology, a section of the journal Frontiers in Neurology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1133819</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>01</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>02</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2023 Xu, Dong, Wang, Song, Niu, Wang, Zhao, Wang, Cong, Han, Hou, Tang, Zhang, Du and Qiu.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Xu, Dong, Wang, Song, Niu, Wang, Zhao, Wang, Cong, Han, Hou, Tang, Zhang, Du and Qiu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<abstract>
<sec>
<title>Objective</title>
<p>To explore the associations of macular microvascular parameters with cerebral small vessel disease (CSVD) in rural-dwelling older adults in China.</p></sec>
<sec>
<title>Methods</title>
<p>This population-based cross-sectional study included 195 participants (age &#x02265; 60 years; 57.4% women) in the optical coherence tomographic angiography (OCTA) sub-study within the Multimodal Interventions to delay Dementia and disability in rural China (MIND-China). Macular microvascular parameters were measured using the OCTA. We automatically estimated volumes of gray matter, white matter, and white matter hyperintensity (WMH), and manually assessed numbers of enlarged perivascular spaces (EPVS) and lacunes on brain magnetic resonance imaging. Data were analyzed with the general linear models.</p></sec>
<sec>
<title>Results</title>
<p>Adjusting for multiple confounders, lower vessel skeleton density (VSD) and higher vessel diameter index (VDI) were significantly associated with larger WMH volume (<italic>P</italic> &#x0003C; 0.05). Lower VSD and foveal density-300 (FD-300) of left eye were significantly associated with lower brain parenchymal volume (<italic>P</italic> &#x0003C; 0.05). In addition, lower areas of foveal avascular zone (FAZ) and FD-300 of left eye were significantly associated with more EPVS (<italic>P</italic> &#x0003C; 0.05). The associations of abnormal macular microvascular parameters with WMH volume were evident mainly among females. Macular microvascular parameters were not associated with lacunes.</p></sec>
<sec>
<title>Conclusion</title>
<p>Macular microvascular signs are associated with WMH, brain parenchymal volume, and EPVS in older adults. The OCTA-assessed macular microvascular parameters can be valuable markers for microvascular lesions in the brain.</p></sec></abstract>
<kwd-group>
<kwd>macular microvascular signs</kwd>
<kwd>cerebral small vessel disease</kwd>
<kwd>optical coherence tomography angiography</kwd>
<kwd>magnetic resonance imaging</kwd>
<kwd>population-based study</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="10"/>
<word-count count="6939"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Cerebral small vessel disease (CSVD) refers to a group of pathological processes with various etiologies affecting the small arteries, venules, and capillaries of the brain (<xref ref-type="bibr" rid="B1">1</xref>). Previous studies have shown that CSVD is associated with clinical stroke and cognitive impairment (<xref ref-type="bibr" rid="B2">2</xref>). Therefore, it is important to identify simple, non-invasive, and inexpensive markers for CSVD.</p>
<p>Microvasculatures in the brain and retina are similar in embryologic origin, anatomic features, metabolic activities, patterns of vascularization, and extracellular deposits (<xref ref-type="bibr" rid="B3">3</xref>). Thus, the retinal microvasculature could be a potential vehicle for studying changes in the cerebral vasculature. Some population-based studies have examined the associations of alterations in retinal microvasculature and imaging markers of CSVD, in which retinal microvascular signs (e.g., retinal focal arteriolar narrowing and arteriovenous nicking) were assessed using fundus photography (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). However, due to limited resolution and sensitivity, traditional fundus imaging techniques can only qualitatively measure signs of microangiopathy (e.g., micro-hemorrhages and micro-aneurysms) or quantitatively measure arteriolar and venular parameters, but cannot directly quantify parameters of the capillary system (e.g., vessel density and vessel diameter index) (<xref ref-type="bibr" rid="B6">6</xref>). As a non-invasive and label-free technique, optical coherence tomography angiography (OCTA) can quantitatively detect the movement of red blood cells at capillary-level resolution and offer imaging markers for retinal microvascular signs, such as retinal vessel density (VD), foveal avascular zone (FAZ), and vessel diameter index (VDI) (<xref ref-type="bibr" rid="B6">6</xref>). Previous studies showed that VD was related to the CSVD burden or global white matter hyperintensity (WMH) (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). However, most of these studies have been conducted in the clinical settings of patients with mild cognitive impairment or Alzheimer&#x00027;s disease (AD), and data from the general population settings are sparse. In addition, cerebral WMH is typically located in paraventricular and deep white matter regions, and etiopathological mechanisms of WMH differ depending on their location (<xref ref-type="bibr" rid="B9">9</xref>). However, the potential differential associations of macular microvascular parameters with paraventricular and deep WMH have rarely been explored. Furthermore, the sex differences in the associations of retinal microvascular signs with CSVD in older adults remain to be clarified. This is important because sex differences in CSVD and retinal capillary plexus have been frequently reported (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>) and there are substantial sex differences in the prevalence of lifestyle risk factors (e.g., smoking and alcohol consumption), especially among rural older adults in China (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>Thus, in this population-based study, we aimed to investigate the associations of macular microvascular signs with markers of CSVD among dementia-free older adults who were living in the rural communities in China. We hypothesize that macular microvascular signs are associated with CSVD markers and that the associations may vary by sex.</p></sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec>
<title>Study design and participants</title>
<p>This population-based cross-sectional study used data from the baseline survey of the Multimodal Interventions to delay Dementia and disability in rural China (MIND-China), which is part of the World-Wide FINGERS Network, as previously reported (<xref ref-type="bibr" rid="B14">14</xref>). In brief, baseline assessments of MIND-China targeted people who were aged &#x02265; 60 years by the end of 2017 and living in the 52 villages of Yanlou Town, Yanggu County, western Shandong Province, China. In March&#x02013;September 2018, 5,765 participants (57.2% female) were examined during the baseline survey of MIND-China (<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>From June 2019 to November 2020, 284 participants accomplished the brain MRI and OCTA examination in Southwest Lu Hospital. The cluster (village)-randomized sampling approach was used in the selection of participants for the MRI and OCTA substudies in MIND-China. Of these, 47 were excluded due to missing data on OCTA images of left eye (<italic>n</italic> = 30) or right eye (<italic>n</italic> = 17). We further excluded 42 participants due to prevalent dementia (<italic>n</italic> = 2), and suboptimal quality of OCTA images (<italic>n</italic> = 31) and brain MRI images (<italic>n</italic> = 9). Therefore, the final analytical sample included 195 dementia-free participants. Compared to the MIND-China participants who were not included in this study (<italic>n</italic> = 5,570), those in the analytical sample (<italic>n</italic> = 195) were slightly younger (mean age 67.95 vs. 70.99 years, <italic>P</italic> &#x0003C; 0.001) and more educated (mean years of schooling education 3.66 vs. 3.16 years, <italic>P</italic> = 0.041), but the two groups did not differ significantly in the distribution of sex (female 57.44 vs. 57.18%, <italic>P</italic> = 0.944).</p>
<p>The MIND-China study was approved by the Ethics Committee at Shandong Provincial Hospital. All participants were informed of the study protocol in detail and signed the informed consent form. Research within MIND-China was conducted in accordance with the ethical principles expressed in the Declaration of Helsinki. MIND-China was registered in the Chinese Clinical Trial Registry (Registration No. ChiCTR1800017758).</p></sec>
<sec>
<title>Data collection and assessments</title>
<p>In March-September 2018, the trained research staff collected data through face-to-face interviews, clinical examinations, neuropsychological tests, and laboratory tests, as part of the baseline examinations of MIND-China (<xref ref-type="bibr" rid="B15">15</xref>). The data included demographic features (e.g., age, sex, and education), lifestyles (e.g., smoking and alcohol consumption), health history (e.g., hypertension, diabetes, and dyslipidemia). Smoking and alcohol intake were classified as never and ever smoking or consuming alcohol. The data collection and assessments were previously described in detail (<xref ref-type="bibr" rid="B15">15</xref>).</p></sec>
<sec>
<title>MRI acquisition and assessment protocols</title>
<p>Participants were scanned on the Philips Ingenia 3.0T MR System in the Southwestern Lu Hospital. The MRI protocols (acquisition, sequences, processing, and quantification) were previously described in detail (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). The protocol included a sagittal three-dimensional T1-weighted fast field echo sequence, an axial T2-weighted fast field echo sequence, and a sagittal three-dimensional fluid attenuated inversion recovery (FLAIR) sequence.</p>
<p>We used AccuBrain<sup>&#x000AE;</sup> (BrainNow Medical Technology Ltd., Shenzhen, Guangdong, China) to assess WMH volume, brain parenchymal volume, and total intracranial volume (ICV), as previously reported (<xref ref-type="bibr" rid="B17">17</xref>). AccuBrain<sup>&#x000AE;</sup> segmented the T1-weighted images and quantified the volumes of gray matter, white matter, and cerebrospinal fluid based on the principle of similarity measures. The ICV was estimated as the sum of gray matter, white matter, and cerebrospinal fluid volume. The brain parenchymal volume was estimated as the sum of gray matter and white matter volume.</p>
<p>To acquire WMH volume, AccuBrain<sup>&#x000AE;</sup> used T2- FLAIR images to calculate the signal contrast between normal brain tissue and WMH, and set the signal threshold to recognize WMH. Based on predefined threshold, WMH was recognized and extracted using T2-FLAIR images. Finally, AccuBrain<sup>&#x000AE;</sup> refined and localized WMH using the transformed T1-weighted brain structure mask extracted from our study sample.</p>
<p>Perivascular spaces (PVS) were microscopic fluid-filled structures that surround the small penetrating blood vessels in the brain. The number of enlarged perivascular spaces (EPVS) was counted on T2-weighted images according to a validated protocol (<xref ref-type="bibr" rid="B18">18</xref>). The EPVS appear linear when imaged parallel to the course of the vessel, and round or ovoid (diameters &#x0003C;3 mm) when imaged perpendicular to the course of the vessel. EPVS of the basal ganglia (BG) and centrum semiovale (CSO) were visually counted by the trained rater (M.Z.) who was unaware of the clinical information, under the supervision of an experienced clinical neurologist (L.S). The rater first reviewed all MRI slices showing BG and CSO regions and then counted the number of EPVS on the slices with the highest number of EPVS (<xref ref-type="bibr" rid="B18">18</xref>). Three months after the initial assessment, EPVS were reassessed on MRI images from 30 randomly selected subjects, and the intra-evaluator correlation coefficients for BG-EPVS and CSO-EPVS were 0.88 and 0.83, respectively. The total number of global EPVS (i.e., BG-EPVS plus CSO-EPVS) was used in our analysis.</p>
<p>Lacune was defined as a region of abnormal signal intensity in a vascular distribution, 3&#x02013;15 mm in size with a cerebrospinal fluid density on the subtraction image (<xref ref-type="bibr" rid="B19">19</xref>). Lacunes were counted on FLAIR images by the trained rater (J.W.) who was blind to clinical information, under the supervision of an experienced clinical neurologist (L.S). Three months after the initial assessment, lacunes were reassessed on MRI images of 200 randomly selected subjects from all participants in MIND-China who undertook brain MRI scans, and the intra-rater correlation coefficients for lacunes was 0.838.</p></sec>
<sec>
<title>Optical coherence tomography angiography acquisition and assessment</title>
<p>The OCTA examination was conducted by ophthalmologists in Southwestern Lu Hospital using Spectralis HRA&#x0002B;OCT (Software Version 1.10.2.0; Heidelberg Engineering, Inc., Heidelberg, Germany). Macular OCTA images of 6 &#x000D7; 6 mm areas (10&#x000B0; &#x000D7; 10&#x000B0; scan angle that included 512 A-scans &#x000D7; 512 B-scans, no pre-determined automatic real time) centered at the fovea were acquired in a dark room without pupil dilation. We scanned the right eye first and then the left eye. We excluded images of suboptimal quality due to eye movement, decentration, defocus, shadow, Z offset, and segmentation error (<xref ref-type="bibr" rid="B20">20</xref>). OCTA images of both eyes were included and analyzed in this study. Because OCTA signals in the deeper layers carry the shadows of blood vessels from the superficial plexus, our analysis only focused on the superficial vascular plexus (extending from the inner limiting membrane to 17 mm above the inner plexiform layer) (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>All macular OCTA images were processed into a binary image in MATLAB (R2019a, MathWorks, Inc.) using a global threshold, hessian filter, and adaptive threshold. Macular microvascular parameters, including vascular density (e.g., VD, VSD, and FD-300) and vascular morphology (e.g., FAZ and VDI), were calculated. FAZ area was defined as the area of the avascular region in the center of the blood flow image (<xref ref-type="bibr" rid="B22">22</xref>). VD was calculated as the ratio of the total image area occupied by the blood flow signal to the total image area in the binary vessel maps (subtract FAZ area) (<xref ref-type="bibr" rid="B22">22</xref>). VSD was calculated as the ratio of the length occupied by the blood flow signal to the total area in the skeletonized vessel map (subtract FAZ area) (<xref ref-type="bibr" rid="B22">22</xref>). VDI, defined as the average diameter of blood vessels, was calculated as the ratio of the area covered by blood flow signal to the length of vessel skeletonization (<xref ref-type="bibr" rid="B23">23</xref>). FD-300 was defined as the foveal vessel density in a 300-&#x003BC;m wide zone around the FAZ (<xref ref-type="bibr" rid="B24">24</xref>).</p></sec>
<sec>
<title>Statistical analysis</title>
<p>We reported frequencies (%) for categorical variables and mean (SD) for continuous variables. Characteristics of study participants by sex were compared using non-parametric test for continuous variables, and chi-square test for categorical variables. General linear models were used to examine the associations of macular microvascular parameters with WMH volume, number of lacunes, brain parenchymal volume, and EPVS count. WMH volume and numbers of lacunes and EPVS were log-transformed due to the skewed distribution. By simultaneously entering the independent variables and their cross-product term into the same model, we tested the statistical interactions of retinal microvascular parameters with sex on CSVD and when statistically significant interaction was detected, we further performed stratified analyses by sex. We reported the main results from two models: model 1 was adjusted for age, sex, and education, if applicable, for ICV; and model 2 was additionally adjusted for alcohol consumption, smoking status, hypertension, diabetes, and dyslipidemia. IBM SPSS Statistics for Windows, Version 25.0 (IBM Corp., Armonk, NY, USA) was used for all the analyses. A two-tailed <italic>P</italic> &#x0003C; 0.05 was considered to be statistically significant.</p></sec></sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Characteristics of the study participants</title>
<p>The mean age of the 195 participants in the analytical sample was 67.95 (SD = 4.01) years, and 57.4% were females. Compared with females, male participants were more educated, and more likely to smoke and drink alcohol, but less likely to have dyslipidemia (<italic>P</italic> &#x0003C; 0.05). In addition, male participants had a smaller FAZ area on both eyes and a smaller brain parenchymal volume but a larger ICV volume (<italic>P</italic> &#x0003C; 0.05; <xref ref-type="table" rid="T1">Table 1</xref>). The two groups did not differ significantly in mean age, FD-300, VD, VSD, VDI (on both eyes), global WMH volume, periventricular WMH (PWMH) volume, deep WMH (DWMH) volume, numbers of EPVS and lacunes, and in the prevalence of diabetes and hypertension (<italic>P</italic> &#x0003E; 0.05).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p> Characteristics of the study participants by sex.</p></caption>
<table frame="box" rules="all">
<thead><tr style="background-color:#919497;color:#ffffff">
<th valign="top" align="left"><bold>Characteristics</bold></th>
<th valign="top" align="center"><bold>Total (<italic>n</italic> = 195)</bold></th>
<th valign="top" align="center"><bold>Female (<italic>n</italic> = 112)</bold></th>
<th valign="top" align="center"><bold>Male (<italic>n</italic> = 83)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center">67.95 (4.01)</td>
<td valign="top" align="center">68.03 (4.09)</td>
<td valign="top" align="center">67.86 (3.91)</td>
<td valign="top" align="center">0.696</td>
</tr> <tr>
<td valign="top" align="left">Education (years)</td>
<td valign="top" align="center">3.66 (3.66)</td>
<td valign="top" align="center">1.91 (2.68)</td>
<td valign="top" align="center">6.02 (3.49)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr> <tr>
<td valign="top" align="left">Ever smoking, <italic>n</italic> (%)</td>
<td valign="top" align="center">63 (32.30)</td>
<td valign="top" align="center">1 (0.90)</td>
<td valign="top" align="center">62 (74.70)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr> <tr>
<td valign="top" align="left">Ever alcohol drinking, <italic>n</italic> (%)</td>
<td valign="top" align="center">81 (41.50)</td>
<td valign="top" align="center">9 (8.00)</td>
<td valign="top" align="center">72 (86.70)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr> <tr>
<td valign="top" align="left">Diabetes, <italic>n</italic> (%)</td>
<td valign="top" align="center">17 (8.70)</td>
<td valign="top" align="center">13 (11.60)</td>
<td valign="top" align="center">4 (4.80)</td>
<td valign="top" align="center">0.097</td>
</tr> <tr>
<td valign="top" align="left">Dyslipidemia, <italic>n</italic> (%)</td>
<td valign="top" align="center">45 (23.10)</td>
<td valign="top" align="center">32 (28.60)</td>
<td valign="top" align="center">13 (15.70)</td>
<td valign="top" align="center">0.034</td>
</tr> <tr>
<td valign="top" align="left">Hypertension, <italic>n</italic> (%)</td>
<td valign="top" align="center">130 (66.70)</td>
<td valign="top" align="center">75 (67.00)</td>
<td valign="top" align="center">55 (66.30)</td>
<td valign="top" align="center">0.918</td>
</tr> <tr>
<td valign="top" align="left" colspan="5" style="background-color:#dee1e1"><bold>CSVD</bold></td>
</tr> <tr>
<td valign="top" align="left">ICV (ml)</td>
<td valign="top" align="center">1,431.03 (128.19)</td>
<td valign="top" align="center">1,369.03 (110.93)</td>
<td valign="top" align="center">1,514.70 (99.41)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr> <tr>
<td valign="top" align="left">Global WMH volume (ml)</td>
<td valign="top" align="center">7.68 (10.46)</td>
<td valign="top" align="center">7.21 (11.05)</td>
<td valign="top" align="center">8.31 (9.63)</td>
<td valign="top" align="center">0.247</td>
</tr> <tr>
<td valign="top" align="left">Periventricular WMH volume (ml)</td>
<td valign="top" align="center">6.38 (9.80)</td>
<td valign="top" align="center">6.00 (10.50)</td>
<td valign="top" align="center">6.89 (8.80)</td>
<td valign="top" align="center">0.163</td>
</tr> <tr>
<td valign="top" align="left">Deep WMH volume (ml)</td>
<td valign="top" align="center">1.30 (1.46)</td>
<td valign="top" align="center">1.21 (1.36)</td>
<td valign="top" align="center">1.41 (1.58)</td>
<td valign="top" align="center">0.595</td>
</tr> <tr>
<td valign="top" align="left">Brain parenchymal volume (L)</td>
<td valign="top" align="center">1.09 (0.10)</td>
<td valign="top" align="center">1.04 (0.09)</td>
<td valign="top" align="center">1.14 (0.08)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr> <tr>
<td valign="top" align="left">EPVS</td>
<td valign="top" align="center">61.48 (29.93)</td>
<td valign="top" align="center">58.05 (28.27)</td>
<td valign="top" align="center">66.10 (31.63)</td>
<td valign="top" align="center">0.088</td>
</tr> <tr>
<td valign="top" align="left">Lacunes<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref></td>
<td valign="top" align="center">0.76 (1.93)</td>
<td valign="top" align="center">0.56 (1.52)</td>
<td valign="top" align="center">1.03 (2.35)</td>
<td valign="top" align="center">0.313</td>
</tr> <tr>
<td valign="top" align="left" colspan="5" style="background-color:#dee1e1"><bold>Macular microvascular index</bold></td>
</tr> <tr>
<td valign="top" align="left">FAZ area (mm<sup>2</sup>), OS</td>
<td valign="top" align="center">0.59 (0.29)</td>
<td valign="top" align="center">0.64 (0.33)</td>
<td valign="top" align="center">0.53 (0.20)</td>
<td valign="top" align="center">0.030</td>
</tr> <tr>
<td valign="top" align="left">FAZ area (mm<sup>2</sup>), OD</td>
<td valign="top" align="center">0.58 (0.25)</td>
<td valign="top" align="center">0.62 (0.25)</td>
<td valign="top" align="center">0.53 (0.24)</td>
<td valign="top" align="center">0.004</td>
</tr> <tr>
<td valign="top" align="left">FD-300 (%), OS</td>
<td valign="top" align="center">0.40 (0.04)</td>
<td valign="top" align="center">0.40 (0.04)</td>
<td valign="top" align="center">0.40 (0.04)</td>
<td valign="top" align="center">0.650</td>
</tr> <tr>
<td valign="top" align="left">FD-300 (%), OD</td>
<td valign="top" align="center">0.40 (0.04)</td>
<td valign="top" align="center">0.40 (0.04)</td>
<td valign="top" align="center">0.39 (0.05)</td>
<td valign="top" align="center">0.281</td>
</tr> <tr>
<td valign="top" align="left">VD (%), OS</td>
<td valign="top" align="center">0.43 (0.03)</td>
<td valign="top" align="center">0.43 (0.03)</td>
<td valign="top" align="center">0.43 (0.03)</td>
<td valign="top" align="center">0.411</td>
</tr> <tr>
<td valign="top" align="left">VD (%), OD</td>
<td valign="top" align="center">0.43 (0.03)</td>
<td valign="top" align="center">0.43 (0.03)</td>
<td valign="top" align="center">0.43 (0.03)</td>
<td valign="top" align="center">0.536</td>
</tr> <tr>
<td valign="top" align="left">VSD (%), OS</td>
<td valign="top" align="center">0.15 (0.01)</td>
<td valign="top" align="center">0.15 (0.01)</td>
<td valign="top" align="center">0.15 (0.01)</td>
<td valign="top" align="center">0.142</td>
</tr> <tr>
<td valign="top" align="left">VSD (%), OD</td>
<td valign="top" align="center">0.15 (0.01)</td>
<td valign="top" align="center">0.15 (0.01)</td>
<td valign="top" align="center">0.15 (0.01)</td>
<td valign="top" align="center">0.558</td>
</tr> <tr>
<td valign="top" align="left">VDI (&#x003BC;m), OS</td>
<td valign="top" align="center">33.10 (2.51)</td>
<td valign="top" align="center">33.45 (2.78)</td>
<td valign="top" align="center">32.62 (2.02)</td>
<td valign="top" align="center">0.056</td>
</tr> <tr>
<td valign="top" align="left">VDI (&#x003BC;m), OD</td>
<td valign="top" align="center">32.96 (2.55)</td>
<td valign="top" align="center">33.02 (2.74)</td>
<td valign="top" align="center">32.89 (2.29)</td>
<td valign="top" align="center">0.920</td>
</tr></tbody>
</table>
<table-wrap-foot>
<p>Data are mean (standard deviation), unless otherwise specified.</p>
<p>OS, left eye; OD, right eye; ICV, intracranial volume; EPVS, enlarged perivascular space; WMH, white matter hyperintensities; CSVD, cerebral small vessel disease; FAZ, foveal avascular zone; FD-300, foveal vessel density in the 300 &#x003BC;m ring; VD, vessel density; VSD, vessel skeleton density; VDI, vessel diameter index.</p>
<fn id="TN1"><label>a</label><p>P-value is for the test of differences between male and female.</p></fn>
<fn id="TN2"><label>b</label><p>Data on lacunes were missing in 6 participants.</p></fn>
</table-wrap-foot>
</table-wrap></sec>
<sec>
<title>Associations of macular microvascular parameters with global cerebral small vessel disease</title>
<p>Adjusting for age, sex, education, and if applicable, for ICV, lower VSD but higher VDI were significantly associated with higher global WMH volume (<italic>P</italic> &#x0003C; 0.05); Lower FD-300 and VSD of the left eye were significantly associated with lower brain parenchymal volume (<italic>P</italic> &#x0003C; 0.05); Lower FD-300 and FAZ areas of the left eye were significantly associated with more EPVS (<italic>P</italic> &#x0003C; 0.05); these associations remained statistically significant even after further controlling for dyslipidemia, diabetes, hypertension, smoking, and alcohol consumption (<italic>P</italic> &#x0003C; 0.05; <xref ref-type="table" rid="T2">Table 2</xref>). The number of lacunes was not significantly associated with any of the examined macular microvascular parameters (<italic>P</italic> &#x0003E; 0.05; <xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p> &#x003B2; coefficient (95% confidence interval) of cerebral small vessel disease associated with macular microvascular parameters (<italic>n</italic> = 195).</p></caption>
<table frame="box" rules="all">
<thead><tr style="background-color:#919497;color:#ffffff">
<th valign="top" align="left" rowspan="2"><bold>Macular microvascular index</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Global WMH volume</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Brain parenchymal volume</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>EPVS</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Lacunes</bold><xref ref-type="table-fn" rid="TN5"><sup><bold>b</bold></sup></xref></th>
</tr> 
</thead>
<tbody>
<tr style="background-color:#919497;color:#ffffff">
<td/>
<td valign="top" align="center"><bold>Model 1</bold><xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td valign="top" align="center"><bold>Model 2</bold><xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td valign="top" align="center"><bold>Model 1</bold><xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td valign="top" align="center"><bold>Model 2</bold><xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td valign="top" align="center"><bold>Model 1</bold><xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td valign="top" align="center"><bold>Model 2</bold><xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td valign="top" align="center"><bold>Model 1</bold><xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td valign="top" align="center"><bold>Model 2</bold><xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
</tr> <tr>
<td valign="top" align="left" colspan="9" style="background-color:#dee1e1"><bold>OS</bold></td>
</tr> <tr>
<td valign="top" align="left">FAZ area (mm<sup>2</sup>)</td>
<td valign="top" align="center">0.01 (&#x02212;0.19, 0.20)</td>
<td valign="top" align="center">0.03 (&#x02212;0.17, 0.22)</td>
<td valign="top" align="center">0.00 (&#x02212;0.01, 0.02)</td>
<td valign="top" align="center">0.01 (&#x02212;0.01, 0.02)</td>
<td valign="top" align="center">&#x02013;0.14 (&#x02013;0.25, &#x02013;0.03)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02013;0.14 (&#x02013;0.25, &#x02013;0.03)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.00 (&#x02212;0.13, 0.14)</td>
<td valign="top" align="center">0.01 (&#x02212;0.12, 0.15)</td>
</tr> <tr>
<td valign="top" align="left">FD-300 (%)</td>
<td valign="top" align="center">&#x02212;0.55 (&#x02212;1.84, 0.73)</td>
<td valign="top" align="center">&#x02212;0.47 (&#x02212;1.75, 0.82)</td>
<td valign="top" align="center">0.09 (0.01, 0.17)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.08 (0.00, 0.16)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02013;0.82 (&#x02013;1.57, &#x02013;0.07)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02013;0.76 (&#x02013;1.51, 0.00)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02212;0.38 (&#x02212;8.42, 4.92)</td>
<td valign="top" align="center">&#x02212;0.28 (&#x02212;1.20, 0.63)</td>
</tr> <tr>
<td valign="top" align="left">VD (%)</td>
<td valign="top" align="center">&#x02212;0.04 (&#x02212;2.09, 2.00)</td>
<td valign="top" align="center">0.10 (&#x02212;1.93, 2.13)</td>
<td valign="top" align="center">0.12 (&#x02212;0.01, 0.24)</td>
<td valign="top" align="center">0.11 (&#x02212;0.02, 0.23)</td>
<td valign="top" align="center">&#x02212;0.60 (&#x02212;1.81, 0.61)</td>
<td valign="top" align="center">&#x02212;0.53 (&#x02212;1.73, 0.67)</td>
<td valign="top" align="center">0.08 (&#x02212;1.38, 1.53)</td>
<td valign="top" align="center">0.23 (&#x02212;1.22, 1.68)</td>
</tr> <tr>
<td valign="top" align="left">VSD (%)</td>
<td valign="top" align="center">&#x02013;4.97 (&#x02013;9.43, &#x02013;0.50)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02013;4.79 (&#x02013;9.24, &#x02013;0.35)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.33 (0.06, 0.60)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.31 (0.04, 0.59)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02212;0.92 (&#x02212;3.59, 1.75)</td>
<td valign="top" align="center">&#x02212;0.56 (&#x02212;3.22, 2.10)</td>
<td valign="top" align="center">1.00 (&#x02212;2.13, 4.13)</td>
<td valign="top" align="center">1.34 (&#x02212;1.81, 4.49)</td>
</tr> <tr>
<td valign="top" align="left">VDI (&#x003BC;m)</td>
<td valign="top" align="center">0.03 (0.01, 0.05)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.03 (0.01, 0.05)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.00 (0.00, 0.00)</td>
<td valign="top" align="center">0.00 (0.00, 0.00)</td>
<td valign="top" align="center">0.00 (&#x02212;0.01, 0.01)</td>
<td valign="top" align="center">0.00 (&#x02212;0.02, 0.01)</td>
<td valign="top" align="center">0.00 (&#x02212;0.02, 0.01)</td>
<td valign="top" align="center">0.00 (&#x02212;0.02, 0.01)</td>
</tr> <tr>
<td valign="top" align="left" colspan="9" style="background-color:#dee1e1"><bold>OD</bold></td>
</tr> <tr>
<td valign="top" align="left">FAZ area (mm<sup>2</sup>)</td>
<td valign="top" align="center">0.15 (&#x02212;0.07, 0.38)</td>
<td valign="top" align="center">0.16 (&#x02212;0.06, 0.38)</td>
<td valign="top" align="center">0.01 (&#x02212;0.01, 0.02)</td>
<td valign="top" align="center">0.01 (&#x02212;0.01, 0.02)</td>
<td valign="top" align="center">0.01 (&#x02212;0.12, 0.15)</td>
<td valign="top" align="center">0.02 (&#x02212;0.11, 0.15)</td>
<td valign="top" align="center">&#x02212;0.02 (&#x02212;0.18, 0.14)</td>
<td valign="top" align="center">&#x02212;0.02 (&#x02212;0.18, 0.14)</td>
</tr> <tr>
<td valign="top" align="left">FD-300 (%)</td>
<td valign="top" align="center">&#x02212;0.69 (&#x02212;2.02, 0.64)</td>
<td valign="top" align="center">&#x02212;0.76 (&#x02212;2.07, 0.55)</td>
<td valign="top" align="center">0.01 (&#x02212;0.07, 0.09)</td>
<td valign="top" align="center">0.01 (&#x02212;0.07, 0.09)</td>
<td valign="top" align="center">&#x02212;0.03 (&#x02212;0.82, 0.76)</td>
<td valign="top" align="center">&#x02212;0.05 (&#x02212;0.82, 0.73)</td>
<td valign="top" align="center">0.95 (0.00, 1.90)<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.90 (&#x02212;0.05, 1.84)</td>
</tr> <tr>
<td valign="top" align="left">VD (%)</td>
<td valign="top" align="center">&#x02212;0.66 (&#x02212;2.67, 1.36)</td>
<td valign="top" align="center">&#x02212;0.80 (&#x02212;2.79, 1.18)</td>
<td valign="top" align="center">0.02 (&#x02212;0.11, 0.14)</td>
<td valign="top" align="center">0.02 (&#x02212;0.10, 0.14)</td>
<td valign="top" align="center">0.12 (&#x02212;1.08, 1.31)</td>
<td valign="top" align="center">0.07 (&#x02212;1.11, 1.25)</td>
<td valign="top" align="center">1.31 (&#x02212;0.12, 2.75)</td>
<td valign="top" align="center">1.21 (&#x02212;0.22, 2.64)</td>
</tr> <tr>
<td valign="top" align="left">VSD (%)</td>
<td valign="top" align="center">&#x02212;3.89 (&#x02212;8.65, 0.86)</td>
<td valign="top" align="center">&#x02212;4.69 (&#x02212;9.40, 0.03)</td>
<td valign="top" align="center">0.08 (&#x02212;0.21, 0.37)</td>
<td valign="top" align="center">0.09 (&#x02212;0.21, 0.38)</td>
<td valign="top" align="center">0.60 (&#x02212;2.23, 3.43)</td>
<td valign="top" align="center">0.50 (&#x02212;2.32, 3.31)</td>
<td valign="top" align="center">1.35 (&#x02212;1.99, 4.68)</td>
<td valign="top" align="center">0.93 (&#x02212;2.42, 4.28)</td>
</tr> <tr>
<td valign="top" align="left">VDI (&#x003BC;m)</td>
<td valign="top" align="center">0.01 (&#x02212;0.01, 0.03)</td>
<td valign="top" align="center">0.01 (&#x02212;0.01, 0.03)</td>
<td valign="top" align="center">0.00 (0.00, 0.00)</td>
<td valign="top" align="center">0.00 (0.00, 0.00)</td>
<td valign="top" align="center">0.00 (&#x02212;0.01, 0.01)</td>
<td valign="top" align="center">0.00 (&#x02212;0.01, 0.01)</td>
<td valign="top" align="center">0.01 (&#x02212;0.01, 0.02)</td>
<td valign="top" align="center">0.01 (&#x02212;0.01, 0.02)</td>
</tr></tbody>
</table>
<table-wrap-foot>
<p>OS, left eye; OD, right eye; FAZ, foveal avascular zone; FD-300, foveal vessel density in the 300 &#x003BC;m ring; VD, vessel density; VSD, vessel skeleton density; VDI, vessel diameter index; WMH, white matter hyperintensities; EPVS, enlarged perivascular spaces.</p>
<fn id="TN3"><label>a</label><p>Model 1 was adjusted for age, sex, education, and if applicable, for ICV; and Model 2 was additionally adjusted for dyslipidemia, diabetes, hypertension, smoking, and alcohol drinking.</p></fn>
<fn id="TN4"><label>&#x0002A;</label><p><italic>P</italic> &#x0003C; 0.05.</p></fn>
<fn id="TN5"><label>b</label><p>Data on lacunes were missing in 6 participants.</p></fn>
</table-wrap-foot>
</table-wrap></sec>
<sec>
<title>Associations of macular microvascular parameters with regional WMH volume</title>
<p>We further examined the associations of macular microvascular parameters with volumes of periventricular and deep WMH. Controlling for age, sex, education, and ICV, lower VSD and higher VDI of the left eye were significantly associated with larger PWMH volume (<italic>P</italic> &#x0003C; 0.05); the associations remained statistically significant even after further controlling for dyslipidemia, diabetes, hypertension, smoking, and alcohol consumption (<italic>P</italic> &#x0003C; 0.05; <xref ref-type="table" rid="T3">Table 3</xref>). In addition, lower VSD of the right eye was significantly associated with larger PWMH volume, even in the fully-adjusted model (<italic>P</italic> &#x0003C; 0.05; <xref ref-type="table" rid="T3">Table 3</xref>). There was no significant association between macular microvascular parameters and DWMH volume (<italic>P</italic> &#x0003E; 0.05; <xref ref-type="table" rid="T3">Table 3</xref>).</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p> &#x003B2; coefficient (95% confidence interval) of deep and periventricular white matter hyperintensity volume associated with macular microvascular parameters (<italic>n</italic> = 195).</p></caption>
<table frame="box" rules="all">
<thead><tr style="background-color:#919497;color:#ffffff">
<th valign="top" align="left" rowspan="2"><bold>Macular microvascular index</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Periventricular WMH volume (ml)</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Deep WMH volume (ml)</bold></th>
</tr>
<tr style="background-color:#919497;color:#ffffff">
<th valign="top" align="center"><bold>Model 1<xref ref-type="table-fn" rid="TN6"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Model 2<xref ref-type="table-fn" rid="TN6"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Model 1<xref ref-type="table-fn" rid="TN6"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Model 2<xref ref-type="table-fn" rid="TN6"><sup>a</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="5" style="background-color:#dee1e1"><bold>OS</bold></td>
</tr> <tr>
<td valign="top" align="left">FAZ area (mm<sup>2</sup>)</td>
<td valign="top" align="center">0.02 (&#x02212;0.17, 0.21)</td>
<td valign="top" align="center">0.04 (&#x02212;0.16, 0.23)</td>
<td valign="top" align="center">&#x02212;0.03 (&#x02212;0.15, 0.08)</td>
<td valign="top" align="center">&#x02212;0.02 (&#x02212;0.13, 0.09)</td>
</tr> <tr>
<td valign="top" align="left">FD-300 (%)</td>
<td valign="top" align="center">&#x02212;0.52 (&#x02212;1.79, 0.75)</td>
<td valign="top" align="center">&#x02212;0.45 (&#x02212;1.73, 0.83)</td>
<td valign="top" align="center">&#x02212;0.46 (&#x02212;1.21, 0.29)</td>
<td valign="top" align="center">&#x02212;0.39 (&#x02212;1.14, 0.36)</td>
</tr> <tr>
<td valign="top" align="left">VD (%)</td>
<td valign="top" align="center">0.07 (&#x02212;1.96, 2.10)</td>
<td valign="top" align="center">0.20 (&#x02212;1.82, 2.21)</td>
<td valign="top" align="center">&#x02212;0.51 (&#x02212;1.71, 0.68)</td>
<td valign="top" align="center">&#x02212;0.39 (&#x02212;1.57, 0.78)</td>
</tr> <tr>
<td valign="top" align="left">VSD (%)</td>
<td valign="top" align="center">&#x02013;4.79 (&#x02013;9.22, &#x02013;0.37)<xref ref-type="table-fn" rid="TN7"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02013;4.65 (&#x02013;9.08, &#x02013;0.22)<xref ref-type="table-fn" rid="TN7"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02212;1.62 (&#x02212;4.26, 1.02)</td>
<td valign="top" align="center">&#x02212;1.52 (&#x02212;4.13, 1.08)</td>
</tr> <tr>
<td valign="top" align="left">VDI (um)</td>
<td valign="top" align="center">0.03 (0.01, 0.05)<xref ref-type="table-fn" rid="TN7"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.03 (0.01, 0.05)<xref ref-type="table-fn" rid="TN8"><sup>&#x0002A;&#x0002A;</sup></xref></td>
<td valign="top" align="center">0.00 (&#x02212;0.01, 0.02)</td>
<td valign="top" align="center">0.01 (&#x02212;0.01, 0.02)</td>
</tr> <tr>
<td valign="top" align="left" colspan="5" style="background-color:#dee1e1"><bold>OD</bold></td>
</tr> <tr>
<td valign="top" align="left">FAZ area (mm<sup>2</sup>)</td>
<td valign="top" align="center">0.18 (&#x02212;0.04, 0.40)</td>
<td valign="top" align="center">0.19 (&#x02212;0.03, 0.41)</td>
<td valign="top" align="center">&#x02212;0.02 (&#x02212;0.15, 0.12)</td>
<td valign="top" align="center">&#x02212;0.01 (&#x02212;0.14, 0.12)</td>
</tr> <tr>
<td valign="top" align="left">FD-300 (%)</td>
<td valign="top" align="center">&#x02212;0.49 (&#x02212;1.81, 0.83)</td>
<td valign="top" align="center">&#x02212;0.55 (&#x02212;1.86, 0.75)</td>
<td valign="top" align="center">&#x02212;0.61 (&#x02212;1.38, 0.17)</td>
<td valign="top" align="center">&#x02212;0.65 (&#x02212;1.41, 0.11)</td>
</tr> <tr>
<td valign="top" align="left">VD (%)</td>
<td valign="top" align="center">&#x02212;0.36 (&#x02212;2.35, 1.64)</td>
<td valign="top" align="center">&#x02212;0.49 (&#x02212;2.46, 1.49)</td>
<td valign="top" align="center">&#x02212;0.82 (&#x02212;2.00, 0.36)</td>
<td valign="top" align="center">&#x02212;0.91 (&#x02212;2.06, 0.24)</td>
</tr> <tr>
<td valign="top" align="left">VSD (%)</td>
<td valign="top" align="center">&#x02212;4.05 (&#x02212;8.75, 0.65)</td>
<td valign="top" align="center">&#x02013;4.76 (&#x02013;9.45, &#x02013;0.07)<xref ref-type="table-fn" rid="TN7"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02212;0.28 (&#x02212;3.09, 2.52)</td>
<td valign="top" align="center">&#x02212;0.85 (&#x02212;3.61, 1.92)</td>
</tr> <tr>
<td valign="top" align="left">VDI (&#x003BC;m)</td>
<td valign="top" align="center">0.01 (&#x02212;0.02, 0.07)</td>
<td valign="top" align="center">0.02 (&#x02212;0.01, 0.04)</td>
<td valign="top" align="center">&#x02212;0.01 (&#x02212;0.02, 0.01)</td>
<td valign="top" align="center">&#x02212;0.01 (&#x02212;0.02, 0.01)</td>
</tr></tbody>
</table>
<table-wrap-foot>
<p>OS, left eye; OD, right eye; FAZ, foveal avascular zone; FD-300, foveal vessel density in the 300 &#x003BC;m ring; VD, vessel density; VSD, vessel skeleton density; VDI, vessel diameter index; WMH, white matter hyperintensities.</p>
<fn id="TN6"><label>a</label><p>Model 1 was adjusted for age, sex, education, if applicable, for ICV; Model 2 was additionally adjusted for dyslipidemia, diabetes, hypertension, smoking, and alcohol consumption.</p></fn>
<fn id="TN7"><label>&#x0002A;</label><p><italic>P</italic> &#x0003C; 0.05.</p></fn>
<fn id="TN8"><label>&#x0002A;&#x0002A;</label><p>P &#x0003C; 0.01.</p></fn>
</table-wrap-foot>
</table-wrap></sec>
<sec>
<title>Interactions of macular microvascular parameters with sex on cerebral small vessel disease</title>
<p>We found statistical interactions of macular microvascular parameters (e.g., VSD and FD-300) with sex on the global WMH and PWMH volumes (<italic>P</italic>-interactions &#x0003C; 0.05). Further analyses stratified by sex showed that macular microvascular parameters (e.g., VSD and FD-300) were significantly associated with higher global WMH and PWMH volumes only among females not in males (<italic>P</italic> &#x0003C; 0.05; <xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Associations of macular microvascular parameters with <bold>(A)</bold> global white matter hyperintensity volume and <bold>(B)</bold> periventricular white matter hyperintensity volume by sex (<italic>n</italic> = 195). CI, confidence interval; OD, right eye; OS, left eye; VSD, vessel skeleton density; FD-300, foveal vessel density in the 300 &#x003BC;m ring; PWMH, periventricular white matter hyperintensity.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fneur-14-1133819-g0001.tif"/>
</fig></sec></sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this population-based cross-sectional study of rural-dwelling Chinese older adults, we found that macular microvascular parameters (e.g., FAZ, FD-300, VSD, and VDI), especially in the left eye, were associated with signs of CSVD (e.g., WMH volume, EPVS count, and brain parenchymal volume). Furthermore, macular microvascular parameters (e.g., VSD and VDI) were associated with larger PWMH volume but not DWMH volume. Our study also revealed that the associations of macular vascular parameters (e.g., VSD and VDI) with volumes of global WMH and PWMH were only evident among females.</p>
<p>The associations between macular microvascular parameters and signs of CSVD have been reported in several case-control studies, but the findings were inconsistent (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B25">25</xref>). The lower vascular density is indicative of reduced retinal blood flow. Our study indicated that lower vascular density (e.g., VSD and FD-300) was associated with higher global WMH volume and more EPVS, which were in line with the previous clinical-based studies (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Furthermore, we revealed that lower VSD and FD-300 were strongly associated with lower brain parenchymal volume, which has rarely been reported in previous studies. The FAZ area is most sensitive to ischemia and enlargement of FAZ area indicates macular ischemia (<xref ref-type="bibr" rid="B28">28</xref>). Our findings suggested that lower FAZ area was associated with more EPVS. However, a clinical-based case-control study in Shanghai found no association between FAZ area and EPVS count, which may be partially due to the fact that the case-control study included young adults (age &#x02265; 18 years) (<xref ref-type="bibr" rid="B26">26</xref>). VDI, which reflects vascular dilation, represents the average vessel caliber regardless of the vessel length (<xref ref-type="bibr" rid="B22">22</xref>). Our data suggested that higher VDI was associated with higher global WMH volume. This may hypothetically be due to the loss of smaller capillaries or compensatory vasodilation of the perfused capillaries secondary to a more hypoxic environment and increased local inflammatory molecules (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Previously, a population-based cohort study has linked the larger venular diameters with the progression of WMH (<xref ref-type="bibr" rid="B5">5</xref>). By contrast, the small-scale case-control study (<italic>n</italic> = 64) in Wuhan, China found no association between VDI and WMH (e.g., PWMH and DWMH), partly due to limited statistical power (<xref ref-type="bibr" rid="B31">31</xref>). Taken together, the findings from our population-based study and previous case-control studies suggest that macular microvascular parameters can be valuable markers for microvascular lesions in the brain.</p>
<p>PWMH and DWMH have distinct etiopathogenic mechanisms. PWMH is more likely to be determined by chronic hemodynamic insufficiency, whereas DWMH may be more attributed to small vessel disease (<xref ref-type="bibr" rid="B32">32</xref>). In line with this view, two hospital-based case-control studies suggested that lower vessel density was associated with severity of DWMH but not PWMH (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B31">31</xref>). However, our study indicated that lower VSD and higher VDI were associated with higher PWMH volume, but not with DWMH volume. The discrepancy across studies may be partly attributed to differences in the study settings (e.g., clinical vs. the general population setting) and characteristics of study populations (e.g., young adults vs. older adults). Thus, further longitudinal studies with larger sample sizes are needed to clarify the potential causal relationship between macular microvascular parameters and WMH by anatomic locations.</p>
<p>In this study, we further examined the interactions of macular microvascular parameters with sex on CSVD markers and found that the associations of macular vascular parameters (e.g., VSD and VDI) with volumes of global WMH and PWMH were only evident among females. This was consistent with the previous community-based study, which showed that associations between WMH severity and arteriovenous nicking were stronger in women than in men (<xref ref-type="bibr" rid="B33">33</xref>). It has been hypothesized that estrogens can increase tissue perfusion of the retina and brain probably by reducing vascular resistance, protecting against oxidative stress, and stimulating synaptogenesis in premenopausal women (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). However, estrogen levels decline markedly after the menopause, the vascular protection of estrogen disappears and women become more susceptible to vascular changes and diseases in the brain (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B36">36</xref>).</p>
<p>Another interesting observation from our study is that the associations between macular microvascular parameters and CSVD were evident mainly in the left eye. This is in agreement with a hospital-based study of adults (age &#x02265; 18 years) in Beijing, which showed that lower VD of the left eye, but not right eye, was associated with higher burdens of WMH and EPVS (<xref ref-type="bibr" rid="B37">37</xref>). This may partially be attributed to structural and functional brain asymmetry occurred during normal human brain development (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B38">38</xref>). Furthermore, previous studies also showed that macular microvascular signs of left eye reflect function and connectivity of the right hemisphere (<xref ref-type="bibr" rid="B39">39</xref>) and the small vascular lesions of the right hemisphere occur earlier and are much more severer than those of the left hemisphere (<xref ref-type="bibr" rid="B40">40</xref>). Finally, there was evidence showing that the left eye appeared to be more sensitive to damage due to hypoxia compared with the right eye (<xref ref-type="bibr" rid="B41">41</xref>).</p>
<p>The pathophysiologic mechanisms underlying the associations of macular microvascular parameters with CSVD are not fully understood but can be speculated. First, anatomically, the retina is regarded as an extension of the diencephalon and has a similar pattern of angiogenesis. Physiologically, similar to the brain, the retina has a highly isolated and protected vascular system (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B42">42</xref>). Second, retinal and brain microvascular lesions share common cardiovascular risk factors (<xref ref-type="bibr" rid="B43">43</xref>). Third, dysfunction of the blood-retina barrier from retina hypoxia owing to long-term exposures to cardiovascular risk factors, which is analogous to and associated with the blood-brain barrier dysfunction, might play a role in the pathogenesis of both retinal microvascular changes and CSVD (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B44">44</xref>). Finally, inflammation and endothelial dysfunction may also be involved in the process of retinal and cerebral microangiopathy (<xref ref-type="bibr" rid="B29">29</xref>). Given the homology of microvasculature in the brain and the retina, the link of macular microvascular parameters with signs of CSVD may reflect underlying pathological processes common in both the brain and the retina (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>The major strengths of our study include the population-based design and comprehensive assessments of macular microvascular and CSVD indicators. Our study also has limitations. First, the cross-sectional study cannot determine a causal relationship. Second, the study sample was relatively small and the statistical power might not be big enough to detect weak-to-moderately strong associations between retinal parameters and markers of CSVD. Third, data on cerebral microbleeds and microinfarcts were not available, which might underestimate the associations of macular microvascular parameters with CSVD. Finally, the study participants were derived from just one rural area and they were also slightly younger and more educated than the MIND-China total sample, which might not be representative of rural population in China. These should be borne in mind when extrapolating the findings to other rural populations.</p></sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusions</title>
<p>In summary, our population-based study of rural-dwelling older adults showed that macular microvascular parameters were independently associated with CSVD markers, and that the observed associations with WMH volume were evident mainly among females. This suggests that quantitative macular microvascular parameters could be useful markers for CSVD. These findings may have potential implications for clinical management of macular microvascular signs in older adults. For instance, ophthalmologists should be aware of the potential link of macular microvascular signs with brain lesions. Structural brain MRI examination may be considered when abnormal macular microvascular signs were detected, especially among older women. Future large-scale prospective cohort studies are warranted to clarify the potential causal relationships of macular microvascular signs with CSVD markers as well as the mechanisms underlying their associations. In addition, the functional consequences (e.g., cognitive and physical dysfunction) of macular microvascular signs among older adults deserve further investigation.</p></sec>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by Ethics Committee at Shandong Provincial Hospital. The patients/participants provided their written informed consent to participate in this study.</p></sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>ZX, QZ, YDu, and CQ: study concept and design. ZX, YW, LS, SN, SW, MZ, JW, YDo, TH, LC, ST, and XH: data collection and assessments. ZX: data analysis and writing the first draft of the manuscript. YDu and CQ: study supervision. All authors have critically revised the manuscript for important intellectual content and approved the final manuscript.</p></sec>
</body>
<back>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>MIND-China was supported in part by grants from the National Natural Science Foundation of China (Grants Nos. 82171175, 81861138008, and 81772448), the Alzheimer&#x00027;s Association Grant (Grant No. AACSFD-22-922844), the National Key R&#x00026;D Program of China Ministry of Sciences and Technology (Grant No. 2017YFC1310100), the Natural Science Foundation of Shandong Province (Grant No. ZR2021MH005), the Academic Promotion Program of Shandong First Medical University (Grant No. 2019QL020), the Integrated Traditional Chinese and Western Medicine Program in Shandong Province (Grant No. YXH2019ZXY008), and the Brain Science and Brain-like Intelligence Technology Research Projects of China (Grant Nos. 2021ZD0201801 and 2021ZD0201808). LC received grants from the Shandong Provincial Key Research and Development Program (Grant No. 2021LCZX03). CQ received grants from the Swedish Research Council (Grant Nos. 2017-05819 and 2020-01574), the Swedish Foundation for International Cooperation in Research and Higher Education (Grant No. CH2019-8320), and Karolinska Institutet (Grant Nos. 2018-01854 and 2020-01456), Stockholm, Sweden. The funding agency had no role in the study design, data collection and analysis, the writing of this manuscript, and in the decision to submit the work for publication.</p>
</sec>
<ack><p>We would like to thank all the participants of the MIND-China Project as well as staff at the Yanlou Town Hospital and Shandong Provincial Hospital who were involved in the data collection and management.</p>
</ack>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pantoni</surname> <given-names>L</given-names></name></person-group>. <article-title>Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges</article-title>. <source>Lancet Neurol.</source> (<year>2010</year>) <volume>9</volume>:<fpage>689</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70104-6</pub-id><pub-id pub-id-type="pmid">20610345</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Debette</surname> <given-names>S</given-names></name> <name><surname>Beiser</surname> <given-names>A</given-names></name> <name><surname>DeCarli</surname> <given-names>C</given-names></name> <name><surname>Au</surname> <given-names>R</given-names></name> <name><surname>Himali</surname> <given-names>JJ</given-names></name> <name><surname>Kelly-Hayes</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Association of mri markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the framingham offspring study</article-title>. <source>Stroke.</source> (<year>2010</year>) <volume>41</volume>:<fpage>600</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.109.570044</pub-id><pub-id pub-id-type="pmid">20167919</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>London</surname> <given-names>A</given-names></name> <name><surname>Benhar</surname> <given-names>I</given-names></name> <name><surname>Schwartz</surname> <given-names>M</given-names></name></person-group>. <article-title>The retina as a window to the brain-from eye research to Cns disorders</article-title>. <source>Nat Rev Neurol.</source> (<year>2013</year>) <volume>9</volume>:<fpage>44</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2012.227</pub-id><pub-id pub-id-type="pmid">23165340</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname> <given-names>C</given-names></name> <name><surname>Cotch</surname> <given-names>MF</given-names></name> <name><surname>Sigurdsson</surname> <given-names>S</given-names></name> <name><surname>Klein</surname> <given-names>R</given-names></name> <name><surname>Jonasson</surname> <given-names>F</given-names></name> <name><surname>Klein</surname> <given-names>BEK</given-names></name> <etal/></person-group>. <article-title>Microvascular lesions in the brain and retina: the age, gene/environment susceptibility-reykjavik study</article-title>. <source>Ann Neurol.</source> (<year>2009</year>) <volume>65</volume>:<fpage>569</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21614</pub-id><pub-id pub-id-type="pmid">19475677</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikram</surname> <given-names>MK</given-names></name> <name><surname>De Jong</surname> <given-names>FJ</given-names></name> <name><surname>Van Dijk</surname> <given-names>EJ</given-names></name> <name><surname>Prins</surname> <given-names>ND</given-names></name> <name><surname>Hofman</surname> <given-names>A</given-names></name> <name><surname>Breteler</surname> <given-names>MMB</given-names></name> <etal/></person-group>. <article-title>Retinal vessel diameters and cerebral small vessel disease: the Rotterdam scan study</article-title>. <source>Brain.</source> (<year>2006</year>) <volume>129</volume>:<fpage>182</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awh688</pub-id><pub-id pub-id-type="pmid">16317022</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spaide</surname> <given-names>RF</given-names></name> <name><surname>Fujimoto</surname> <given-names>JG</given-names></name> <name><surname>Waheed</surname> <given-names>NK</given-names></name> <name><surname>Sadda</surname> <given-names>SR</given-names></name> <name><surname>Staurenghi</surname> <given-names>G</given-names></name></person-group>. <article-title>Optical coherence tomography angiography</article-title>. <source>Prog Retin Eye Res.</source> (<year>2018</year>) <volume>64</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2017.11.003</pub-id><pub-id pub-id-type="pmid">29229445</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J-Y</given-names></name> <name><surname>Kim</surname> <given-names>JP</given-names></name> <name><surname>Jang</surname> <given-names>H</given-names></name> <name><surname>Kim</surname> <given-names>J</given-names></name> <name><surname>Kang</surname> <given-names>SH</given-names></name> <name><surname>Kim</surname> <given-names>JS</given-names></name> <etal/></person-group>. <article-title>Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases</article-title>. <source>Alzheimers Res Ther.</source> (<year>2020</year>) <volume>12</volume>:<fpage>73</fpage>. <pub-id pub-id-type="doi">10.1186/s13195-020-00638-x</pub-id><pub-id pub-id-type="pmid">32527301</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>C</given-names></name> <name><surname>Kwapong</surname> <given-names>WR</given-names></name> <name><surname>Xu</surname> <given-names>S</given-names></name> <name><surname>Muse</surname> <given-names>FM</given-names></name> <name><surname>Yan</surname> <given-names>J</given-names></name> <name><surname>Qu</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Structural and microvascular changes in the macular are associated with severity of white matter lesions</article-title>. <source>Front Neurol.</source> (<year>2020</year>) <volume>11</volume>:<fpage>521</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2020.00521</pub-id><pub-id pub-id-type="pmid">32714262</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wardlaw</surname> <given-names>JM</given-names></name> <name><surname>Smith</surname> <given-names>EE</given-names></name> <name><surname>Biessels</surname> <given-names>GJ</given-names></name> <name><surname>Cordonnier</surname> <given-names>C</given-names></name> <name><surname>Fazekas</surname> <given-names>F</given-names></name> <name><surname>Frayne</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration</article-title>. <source>Lancet Neurol.</source> (<year>2013</year>) <volume>12</volume>:<fpage>822</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(13)70124-8</pub-id><pub-id pub-id-type="pmid">23867200</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000E9;nez-S&#x000E1;nchez</surname> <given-names>L</given-names></name> <name><surname>Hamilton</surname> <given-names>OKL</given-names></name> <name><surname>Clancy</surname> <given-names>U</given-names></name> <name><surname>Backhouse</surname> <given-names>EV</given-names></name> <name><surname>Stewart</surname> <given-names>CR</given-names></name> <name><surname>Stringer</surname> <given-names>MS</given-names></name> <etal/></person-group>. <article-title>Sex differences in cerebral small vessel disease: a systematic review and meta-analysis</article-title>. <source>Front Neurol.</source> (<year>2021</year>) <volume>12</volume>:<fpage>756887</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2021.756887</pub-id><pub-id pub-id-type="pmid">34777227</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>B</given-names></name> <name><surname>Zhu</surname> <given-names>X</given-names></name> <name><surname>Yang</surname> <given-names>K</given-names></name> <name><surname>Xiao</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <name><surname>Shi</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Age- and sex-related differences in the retinal capillary plexus in healthy Chinese adults</article-title>. <source>Eye Vis.</source> (<year>2022</year>) <volume>9</volume>:<fpage>38</fpage>. <pub-id pub-id-type="doi">10.1186/s40662-022-00307-0</pub-id><pub-id pub-id-type="pmid">36180939</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>A</given-names></name> <name><surname>Liang</surname> <given-names>Y</given-names></name> <name><surname>Yan</surname> <given-names>Z</given-names></name> <name><surname>Sun</surname> <given-names>B</given-names></name> <name><surname>Cai</surname> <given-names>C</given-names></name> <name><surname>Jiang</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Highly prevalent and poorly controlled cardiovascular risk factors among chinese elderly people living in the rural community</article-title>. <source>Eur J Prev Cardiol.</source> (<year>2014</year>) <volume>21</volume>:<fpage>1267</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1177/2047487313487621</pub-id><pub-id pub-id-type="pmid">23598595</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>X</given-names></name> <name><surname>Jiang</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Liang</surname> <given-names>Y</given-names></name> <name><surname>Dong</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study</article-title>. <source>BMC Geriatr.</source> (<year>2021</year>) <volume>21</volume>:<fpage>158</fpage>. <pub-id pub-id-type="doi">10.1186/s12877-021-02116-x</pub-id><pub-id pub-id-type="pmid">33663413</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kivipelto</surname> <given-names>M</given-names></name> <name><surname>Mangialasche</surname> <given-names>F</given-names></name> <name><surname>Snyder</surname> <given-names>HM</given-names></name> <name><surname>Allegri</surname> <given-names>R</given-names></name> <name><surname>Andrieu</surname> <given-names>S</given-names></name> <name><surname>Arai</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>World-wide fingers network: a global approach to risk reduction and prevention of dementia</article-title>. <source>Alzheimers Dement.</source> (<year>2020</year>) <volume>16</volume>:<fpage>1078</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1002/alz.12123</pub-id><pub-id pub-id-type="pmid">32627328</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Han</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>Z</given-names></name> <name><surname>Cong</surname> <given-names>L</given-names></name> <name><surname>Tang</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Health status and risk profiles for brain aging of rural-dwelling older adults: data from the interdisciplinary baseline assessments in mind-China</article-title>. <source>Alzheimers Dement (N Y).</source> (<year>2022</year>) <volume>8</volume>:<fpage>e12254</fpage>. <pub-id pub-id-type="doi">10.1002/trc2.12254</pub-id><pub-id pub-id-type="pmid">35441085</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Cong</surname> <given-names>L</given-names></name> <name><surname>Hou</surname> <given-names>T</given-names></name> <name><surname>Luo</surname> <given-names>Y</given-names></name> <name><surname>Shi</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>High-density lipoprotein cholesterol and brain aging amongst rural-dwelling older adults: a population-based magnetic resonance imaging study</article-title>. <source>Eur J Neurol.</source> (<year>2021</year>) <volume>28</volume>:<fpage>2882</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/ene.14939</pub-id><pub-id pub-id-type="pmid">34031948</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrigo</surname> <given-names>J</given-names></name> <name><surname>Shi</surname> <given-names>L</given-names></name> <name><surname>Luo</surname> <given-names>Y</given-names></name> <name><surname>Chen</surname> <given-names>Q</given-names></name> <name><surname>Chu</surname> <given-names>WCW</given-names></name> <name><surname>Mok</surname> <given-names>VCT</given-names></name></person-group>. <article-title>Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer&#x00027;s disease imaging biomarker</article-title>. <source>Acta Radiol.</source> (<year>2019</year>) <volume>60</volume>:<fpage>769</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1177/0284185118795327</pub-id><pub-id pub-id-type="pmid">30185071</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname> <given-names>GM</given-names></name> <name><surname>Chappell</surname> <given-names>FM</given-names></name> <name><surname>Morris</surname> <given-names>Z</given-names></name> <name><surname>Wardlaw</surname> <given-names>JM</given-names></name></person-group>. <article-title>Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability</article-title>. <source>Cerebrovasc Dis.</source> (<year>2015</year>) <volume>39</volume>:<fpage>224</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1159/000375153</pub-id><pub-id pub-id-type="pmid">25823458</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Han</surname> <given-names>F</given-names></name> <name><surname>Liang</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>M</given-names></name> <name><surname>Zhang</surname> <given-names>D</given-names></name> <name><surname>Zhai</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Lacune and large perivascular space: two kinds of cavities are of different risk factors and stroke risk</article-title>. <source>Cerebrovasc Dis.</source> (<year>2020</year>) <volume>49</volume>:<fpage>522</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1159/000508732</pub-id><pub-id pub-id-type="pmid">33091907</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamalipour</surname> <given-names>A</given-names></name> <name><surname>Moghimi</surname> <given-names>S</given-names></name> <name><surname>Hou</surname> <given-names>H</given-names></name> <name><surname>Penteado</surname> <given-names>RC</given-names></name> <name><surname>Oh</surname> <given-names>WH</given-names></name> <name><surname>Proudfoot</surname> <given-names>JA</given-names></name> <etal/></person-group>. <article-title>Oct angiography artifacts in glaucoma</article-title>. <source>Ophthalmology.</source> (<year>2021</year>) <volume>128</volume>:<fpage>1426</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2021.03.036</pub-id><pub-id pub-id-type="pmid">33819524</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname> <given-names>DM</given-names></name> <name><surname>Dubis</surname> <given-names>AM</given-names></name> <name><surname>Chen</surname> <given-names>FK</given-names></name> <name><surname>Zawadzki</surname> <given-names>RJ</given-names></name> <name><surname>Sampson</surname> <given-names>DD</given-names></name></person-group>. <article-title>Towards standardizing retinal optical coherence tomography angiography: a review</article-title>. <source>Light Sci Appl.</source> (<year>2022</year>) <volume>11</volume>:<fpage>63</fpage>. <pub-id pub-id-type="doi">10.1038/s41377-022-00740-9</pub-id><pub-id pub-id-type="pmid">35304441</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalra</surname> <given-names>G</given-names></name> <name><surname>Zarranz-Ventura</surname> <given-names>J</given-names></name> <name><surname>Chahal</surname> <given-names>R</given-names></name> <name><surname>Bernal-Morales</surname> <given-names>C</given-names></name> <name><surname>Lupidi</surname> <given-names>M</given-names></name> <name><surname>Chhablani</surname> <given-names>J</given-names></name></person-group>. <article-title>Optical coherence tomography (Oct) angiolytics: a review of oct angiography quantitative biomarkers</article-title>. <source>Surv Ophthalmol.</source> (<year>2022</year>) <volume>67</volume>:<fpage>1118</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.survophthal.2021.11.002</pub-id><pub-id pub-id-type="pmid">34748794</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Q</given-names></name> <name><surname>Sun</surname> <given-names>H</given-names></name> <name><surname>Huang</surname> <given-names>X</given-names></name> <name><surname>Qu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Retinal microvascular metrics in untreated essential hypertensives using optical coherence tomography angiography</article-title>. <source>Graefes Arch Clin Exp Ophthalmol.</source> (<year>2021</year>) <volume>259</volume>:<fpage>395</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1007/s00417-020-04714-8</pub-id><pub-id pub-id-type="pmid">32613576</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inanc</surname> <given-names>M</given-names></name> <name><surname>Tekin</surname> <given-names>K</given-names></name> <name><surname>Kiziltoprak</surname> <given-names>H</given-names></name> <name><surname>Ozalkak</surname> <given-names>S</given-names></name> <name><surname>Doguizi</surname> <given-names>S</given-names></name> <name><surname>Aycan</surname> <given-names>Z</given-names></name></person-group>. <article-title>Changes in retinal microcirculation precede the clinical onset of diabetic retinopathy in children with type 1 diabetes mellitus</article-title>. <source>Am J Ophthalmol.</source> (<year>2019</year>) <volume>207</volume>:<fpage>37</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajo.2019.04.011</pub-id><pub-id pub-id-type="pmid">31009594</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname> <given-names>W</given-names></name> <name><surname>Kwapong</surname> <given-names>WR</given-names></name> <name><surname>Xie</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Guo</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Retinal microvasculature and imaging markers of brain frailty in normal aging adults</article-title>. <source>Front Aging Neurosci.</source> (<year>2022</year>) <volume>14</volume>:<fpage>945964</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2022.945964</pub-id><pub-id pub-id-type="pmid">36072485</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>W</given-names></name> <name><surname>Zhou</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Li</surname> <given-names>P</given-names></name> <name><surname>Hou</surname> <given-names>J</given-names></name> <name><surname>Gao</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Fundus changes evaluated by octa in patients with cerebral small vessel disease and their correlations: a cross-sectional study</article-title>. <source>Front Neurol.</source> (<year>2022</year>) <volume>13</volume>:<fpage>843198</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2022.843198</pub-id><pub-id pub-id-type="pmid">35547389</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Wei</surname> <given-names>Q</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <name><surname>Cao</surname> <given-names>S</given-names></name> <name><surname>Chen</surname> <given-names>C</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>The vessel density of the superficial retinal capillary plexus as a new biomarker in cerebral small vessel disease: an optical coherence tomography angiography study</article-title>. <source>Neurol Sci.</source> (<year>2021</year>) <volume>42</volume>:<fpage>3615</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-021-05038-z</pub-id><pub-id pub-id-type="pmid">33432462</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulut</surname> <given-names>M</given-names></name> <name><surname>Kurtulu&#x0015F;</surname> <given-names>F</given-names></name> <name><surname>G&#x000F6;zkaya</surname> <given-names>O</given-names></name> <name><surname>Erol</surname> <given-names>MK</given-names></name> <name><surname>Cengiz</surname> <given-names>A</given-names></name> <name><surname>Akidan</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Evaluation of optical coherence tomography angiographic findings in Alzheimer&#x00027;s type dementia</article-title>. <source>Br J Ophthalmol.</source> (<year>2018</year>) <volume>102</volume>:<fpage>233</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/bjophthalmol-2017-310476</pub-id><pub-id pub-id-type="pmid">28600299</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lenin</surname> <given-names>R</given-names></name> <name><surname>Thomas</surname> <given-names>SM</given-names></name> <name><surname>Gangaraju</surname> <given-names>R</given-names></name></person-group>. <article-title>Endothelial activation and oxidative stress in neurovascular defects of the retina</article-title>. <source>Curr Pharm Des.</source> (<year>2018</year>) <volume>24</volume>:<fpage>4742</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.2174/1381612825666190115122622</pub-id><pub-id pub-id-type="pmid">30644342</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>TY</given-names></name> <name><surname>Islam</surname> <given-names>FMA</given-names></name> <name><surname>Klein</surname> <given-names>R</given-names></name> <name><surname>Klein</surname> <given-names>BEK</given-names></name> <name><surname>Cotch</surname> <given-names>MF</given-names></name> <name><surname>Castro</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (Mesa)</article-title>. <source>Invest Ophthalmol Vis Sci.</source> (<year>2006</year>) <volume>47</volume>:<fpage>2341</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.05-1539</pub-id><pub-id pub-id-type="pmid">16723443</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>T</given-names></name> <name><surname>Qu</surname> <given-names>W</given-names></name> <name><surname>Pan</surname> <given-names>D</given-names></name> <name><surname>Qiu</surname> <given-names>Q</given-names></name> <name><surname>Wu</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Abnormalities of retinal structure and microvasculature are associated with cerebral white matter hyperintensities</article-title>. <source>Eur J Neurol.</source> (<year>2022</year>) <volume>29</volume>:<fpage>2289</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1111/ene.15378</pub-id><pub-id pub-id-type="pmid">35503727</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>KW</given-names></name> <name><surname>MacFall</surname> <given-names>JR</given-names></name> <name><surname>Payne</surname> <given-names>ME</given-names></name></person-group>. <article-title>Classification of white matter lesions on magnetic resonance imaging in elderly persons</article-title>. <source>Biol Psychiatry.</source> (<year>2008</year>) <volume>64</volume>:<fpage>273</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.03.024</pub-id><pub-id pub-id-type="pmid">18471801</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Longstreth</surname> <given-names>W</given-names></name> <name><surname>Larsen</surname> <given-names>EKM</given-names></name> <name><surname>Klein</surname> <given-names>R</given-names></name> <name><surname>Wong</surname> <given-names>TY</given-names></name> <name><surname>Sharrett</surname> <given-names>AR</given-names></name> <name><surname>Lefkowitz</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: the cardiovascular health study</article-title>. <source>Am J Epidemiol.</source> (<year>2007</year>) <volume>165</volume>:<fpage>78</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwj350</pub-id><pub-id pub-id-type="pmid">17041135</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nuzzi</surname> <given-names>R</given-names></name> <name><surname>Scalabrin</surname> <given-names>S</given-names></name> <name><surname>Becco</surname> <given-names>A</given-names></name> <name><surname>Panzica</surname> <given-names>G</given-names></name></person-group>. <article-title>Gonadal hormones and retinal disorders: a review</article-title>. <source>Front Endocrinol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>66</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2018.00066</pub-id><pub-id pub-id-type="pmid">29551993</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname> <given-names>DN</given-names></name> <name><surname>Duckles</surname> <given-names>SP</given-names></name> <name><surname>Pelligrino</surname> <given-names>DA</given-names></name></person-group>. <article-title>Influence of sex steroid hormones on cerebrovascular function</article-title>. <source>J Appl Physiol.</source> (<year>2006</year>) <volume>101</volume>:<fpage>1252</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.01095.2005</pub-id><pub-id pub-id-type="pmid">16794020</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lohner</surname> <given-names>V</given-names></name> <name><surname>Pehlivan</surname> <given-names>G</given-names></name> <name><surname>Sanroma</surname> <given-names>G</given-names></name> <name><surname>Miloschewski</surname> <given-names>A</given-names></name> <name><surname>Schirmer</surname> <given-names>MD</given-names></name> <name><surname>St&#x000F6;cker</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Relation between sex, menopause, and white matter hyperintensities: the rhineland study</article-title>. <source>Neurology.</source> (<year>2022</year>) <volume>99</volume>:<fpage>e935</fpage>&#x02013;<lpage>e43</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000200782</pub-id><pub-id pub-id-type="pmid">35768207</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Qu</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name></person-group>. <article-title>Association between retinal vessel density and neuroimaging features and cognitive impairment in cerebral small vessel disease</article-title>. <source>Clin Neurol Neurosurg.</source> (<year>2022</year>) <volume>221</volume>:<fpage>107407</fpage>. <pub-id pub-id-type="doi">10.1016/j.clineuro.2022.107407</pub-id><pub-id pub-id-type="pmid">35933965</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saltoun</surname> <given-names>K</given-names></name> <name><surname>Adolphs</surname> <given-names>R</given-names></name> <name><surname>Paul</surname> <given-names>LK</given-names></name> <name><surname>Sharma</surname> <given-names>V</given-names></name> <name><surname>Diedrichsen</surname> <given-names>J</given-names></name> <name><surname>Yeo</surname> <given-names>BTT</given-names></name> <etal/></person-group>. <article-title>Dissociable brain structural asymmetry patterns reveal unique phenome-wide profiles</article-title>. <source>Nat Hum Behav.</source> (<year>2022</year>) <volume>7</volume>:<fpage>251</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/s41562-022-01461-0</pub-id><pub-id pub-id-type="pmid">36344655</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>C</given-names></name> <name><surname>Burtis</surname> <given-names>DB</given-names></name> <name><surname>Ding</surname> <given-names>M</given-names></name> <name><surname>Mo</surname> <given-names>J</given-names></name> <name><surname>Williamson</surname> <given-names>JB</given-names></name> <name><surname>Heilman</surname> <given-names>KM</given-names></name></person-group>. <article-title>The effects of left and right monocular viewing on hemispheric activation</article-title>. <source>J Clin Exp Neuropsychol.</source> (<year>2018</year>) <volume>40</volume>:<fpage>198</fpage>&#x02013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1080/13803395.2017.1332169</pub-id><pub-id pub-id-type="pmid">28552020</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>H</given-names></name> <name><surname>Tang</surname> <given-names>Y</given-names></name> <name><surname>Yuan</surname> <given-names>Z</given-names></name></person-group>. <article-title>White matter asymmetries in patients with cerebral small vessel disease</article-title>. <source>J Integr Neurosci.</source> (<year>2018</year>) <volume>17</volume>:<fpage>159</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.31083/JIN-170037</pub-id><pub-id pub-id-type="pmid">29526848</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Martin</surname> <given-names>E</given-names></name> <name><surname>Ruiz-de Gopegui</surname> <given-names>E</given-names></name> <name><surname>Le&#x000F3;n-Latre</surname> <given-names>M</given-names></name> <name><surname>Otin</surname> <given-names>S</given-names></name> <name><surname>Altemir</surname> <given-names>I</given-names></name> <name><surname>Polo</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>Influence of cardiovascular condition on retinal and retinal nerve fiber layer measurements</article-title>. <source>PLoS ONE.</source> (<year>2017</year>) <volume>12</volume>:<fpage>e0189929</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0189929</pub-id><pub-id pub-id-type="pmid">29272287</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patton</surname> <given-names>N</given-names></name> <name><surname>Aslam</surname> <given-names>T</given-names></name> <name><surname>Macgillivray</surname> <given-names>T</given-names></name> <name><surname>Pattie</surname> <given-names>A</given-names></name> <name><surname>Deary</surname> <given-names>IJ</given-names></name> <name><surname>Dhillon</surname> <given-names>B</given-names></name></person-group>. <article-title>Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures</article-title>. <source>J Anat.</source> (<year>2005</year>) <volume>206</volume>:<fpage>319</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7580.2005.00395.x</pub-id><pub-id pub-id-type="pmid">15817102</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname> <given-names>CY-l</given-names></name> <name><surname>Ikram</surname> <given-names>MK</given-names></name> <name><surname>Sabanayagam</surname> <given-names>C</given-names></name> <name><surname>Wong</surname> <given-names>TY</given-names></name></person-group>. <article-title>Retinal microvasculature as a model to study the manifestations of hypertension</article-title>. <source>Hypertension.</source> (<year>2012</year>) <volume>60</volume>:<fpage>1094</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.111.189142</pub-id><pub-id pub-id-type="pmid">23045470</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>SM</given-names></name> <name><surname>Jansen</surname> <given-names>JFA</given-names></name> <name><surname>Zhang</surname> <given-names>CE</given-names></name> <name><surname>Hoff</surname> <given-names>EI</given-names></name> <name><surname>Staals</surname> <given-names>J</given-names></name> <name><surname>van Oostenbrugge</surname> <given-names>RJ</given-names></name> <etal/></person-group>. <article-title>Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease</article-title>. <source>Neurology.</source> (<year>2019</year>) <volume>92</volume>:<fpage>e1669</fpage>&#x02013;<lpage>e77</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000007263</pub-id><pub-id pub-id-type="pmid">30867275</pub-id></citation></ref>
</ref-list> 
</back>
</article> 